Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Commentary on: OpenUrlCrossRefPubMed
There is controversy over the use of self-monitoring blood glucose (SMBG) in patients with type 2 diabetes mellitus (T2DM) not taking insulin. SMBG for patients taking insulin is supported by necessity to closely monitor glucose and potential fluctuations. Many individuals with T2DM use SMBG to guide treatment decisions while others use SMBG to fulfil clinician recommendations to check blood glucose levels. Since many patients with T2DM are not always prone to hypoglycaemia, the utility of the frequent testing is debatable. In addition, the financial implications of SMBG can be tremendous, and SMBG may reduce quality of life. Third party payers will not always support SMBG with high frequency testing in T2DM non-insulin users. Aakre and colleagues examine SMBG in non-insulin T2DM with regard to recommendations put forth by clinical …
Competing interests None.